Trials / Recruiting
RecruitingNCT06056271
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Volta Medical · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AF Ablation | Percutaneous, catheter-based ablation of atrial fibrillation |
Timeline
- Start date
- 2024-03-19
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2023-09-28
- Last updated
- 2025-12-10
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06056271. Inclusion in this directory is not an endorsement.